|
|
| Zeile 16: |
Zeile 16: |
| | | | |
| | *'''[[Respiration mgmt]]''' | | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=32320506|t=2020. Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED s Experience During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32340583|t=2020. COVID-19 pandemic: overview of protective-ventilation strategy in ARDS patients |pdf=|usr=}}
| |
| − | {{tp|p=32203672|t=2020. Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19?associated Acute Respiratory Distress Syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32200645|t=2020. Lung Recruitability in COVID-19?associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study |pdf=|usr=}}
| |
| − | {{tp|p=32366770|t=2020. COVID-19: Common Critical and Practical Questions |pdf=|usr=}}
| |
| − | {{tp|p=32369396|t=2020. Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive IPAH and COVID-19 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32311297|t=2020. COVID-19: First Do No Harm |pdf=|usr=}}
| |
| − | {{tp|p=32281885|t=2020. Basing Respiratory Management of COVID-19 on Physiological Principles |pdf=|usr=}}
| |
| − | {{tp|p=32348678|t=2020. Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study |pdf=|usr=}}
| |
| − | {{tp|p=32281886|t=2020. COVID-19 and Home Positive Airway Pressure (PAP) Therapy |pdf=|usr=}}
| |
| − | {{tp|p=32221970|t=2020. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists |pdf=|usr=}}
| |
| − | {{tp|p=32271942|t=2020. Coping with COVID-19: ventilator splitting with differential driving pressures using standard hospital equipment |pdf=|usr=}}
| |
| − | {{tp|p=32246843|t=2020. The use of high-flow nasal oxygen in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32348561|t=2020. Adapting re-usable elastomeric respirators to utilise anaesthesia circuit filters using a 3D-printed adaptor - a potential alternative to address N95 shortages during the COVID-19 pandemic |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| Zeile 38: |
Zeile 23: |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32368928|t=2020. Can Chest CT Features Distinguish Patients With Negative From Those With Positive Initial RT-PCR Results for Coronavirus Disease (COVID-19)?|pdf=|usr=}}
| |
| − | {{tp|p=32208010|t=2020. CT Findings of Coronavirus Disease (COVID-19) Severe Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32125873|t=2020. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study |pdf=|usr=}}
| |
| − | {{tp|p=32108495|t=2020. Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32223665|t=2020. Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT |pdf=|usr=}}
| |
| − | {{tp|p=32181672|t=2020. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32174129|t=2020. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32174128|t=2020. Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China |pdf=|usr=}}
| |
| − | {{tp|p=32134681|t=2020. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32130038|t=2020. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management |pdf=|usr=}}
| |
| − | {{tp|p=32255684|t=2020. Vascular Changes Detected With Thoracic CT in Coronavirus Disease (COVID-19) Might Be Significant Determinants for Accurate Diagnosis and Optimal Patient Management |pdf=|usr=}}
| |
| − | {{tp|p=32255683|t=2020. Clinical Features and Chest CT Manifestations of Coronavirus Disease (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32352310|t=2020. Atypical Imaging Findings in Leukemia With SARS-CoV-2 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32352308|t=2020. Pediatric SARS, H1N1, MERS, EVALI, and Now Coronavirus Disease (COVID-19) Pneumonia: What Radiologists Need to Know |pdf=|usr=}}
| |
| − | {{tp|p=32319792|t=2020. Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT |pdf=|usr=}}
| |
| − | {{tp|p=32239972|t=2020. Differential Diagnosis for Coronavirus Disease (COVID-19): Beyond Radiologic Features |pdf=|usr=}}
| |
| − | {{tp|p=32302207|t=2020. CT of Coronavirus Disease (COVID-19) Pneumonia: A Reference Standard Is Needed |pdf=|usr=}}
| |
| − | {{tp|p=32301631|t=2020. Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms |pdf=|usr=}}
| |
| − | {{tp|p=32298150|t=2020. Radiologic Findings of Coronavirus Disease (COVID-19): Clinical Correlation Is Recommended |pdf=|usr=}}
| |
| − | {{tp|p=32298149|t=2020. Chest CT and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date |pdf=|usr=}}
| |
| − | {{tp|p=32298148|t=2020. Follow-Up Information About the Four Pregnant Patients With Coronavirus Disease (COVID-19) Pneumonia Who Were Still in the Hospital at the End of Our Study |pdf=|usr=}}
| |
| − | {{tp|p=32286875|t=2020. CT Is Not a Screening Tool for Coronavirus Disease (COVID-19) Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32286871|t=2020. CT Findings of Pregnant Women With Coronavirus Disease (COVID-19) Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32233926|t=2020. Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32333546|t=2020. Challenges and Opportunities for Lung Ultrasound in Novel Coronavirus Disease (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32333544|t=2020. Point-of-Care Lung Ultrasound Findings in Patients with Novel Coronavirus Disease (COVID-19) Pneumonia |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 88: |
Zeile 45: |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32369190|t=2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series |pdf=|usr=}}
| |
| − | {{tp|p=32298486|t=2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19) |pdf=|usr=}}
| |
| − | {{tp|p=32360743|t=ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19 |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 119: |
Zeile 72: |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32267008|t=2020. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability |pdf=|usr=}}
| |
| − | {{tp|p=32374815|t=ä. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
| − | {{tp|p=32212392|t=ä. Leukoerythroblastic reaction in a patient with COVID?19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32356307|t=2020. From Hematologist s desk: The effect of COVID-19 on the blood system |pdf=|usr=}}
| |
| − | {{tp|p=32282949|t=2020. Hematological findings and complications of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32129508|t=2020. Hematologic parameters in patients with COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32339335|t=2020. Hematologic parameters in patients with COVID-19 infection: a reply |pdf=|usr=}}
| |
| − | {{tp|p=32279346|t=2020. Morphological anomalies of circulating blood cells in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32371745|t=2020. Unexpected Severe Thrombocytopenia in the COVID-19 Positive Parturient |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 140: |
Zeile 81: |
| | | | |
| | *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32285431|t=2020. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know |pdf=|usr=}}
| |
| − | {{tp|p=32223077|t=ä. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID?19 |pdf=|usr=}}
| |
| − | {{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}}
| |
| − | {{tp|p=32336042|t=2020. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19 |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
| Zeile 161: |
Zeile 97: |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32377677|t=ä. COVID-19 in Older People: A Rapid Clinical Review |pdf=|usr=}}
| |
| − | {{tp|p=32371056|t=ä. Care of critically ill pregnant patients with coronavirus disease 2019: a case series |pdf=|usr=}}
| |
| − | {{tp|p=32228252|t=2020. COVID-19, ACE2, and the cardiovascular consequences |pdf=|usr=}}
| |
| − | {{tp|p=32277845|t=2020. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates |pdf=|usr=}}
| |
| − | {{tp|p=32259279|t=2020. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies |pdf=|usr=}}
| |
| − | {{tp|p=32356302|t=2020. Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations |pdf=|usr=}}
| |
| − | {{tp|p=32141062|t=2020. Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?|pdf=|usr=}}
| |
| − | {{tp|p=32212348|t=2020. Why is COVID-19 so mild in children?|pdf=|usr=}}
| |
| − | {{tp|p=32339307|t=2020. Additional hypotheses about why COVID-19 is milder in children than adults |pdf=|usr=}}
| |
| − | {{tp|p=32279351|t=2020. We urgently need guidelines for managing COVID-19 in children with comorbidities |pdf=|usr=}}
| |
| − | {{tp|p=32310898|t=2020. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32186894|t=2020. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis |pdf=|usr=}}
| |
| − | {{tp|p=32348598|t=2020. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient |pdf=|usr=}}
| |
| − | {{tp|p=32359205|t=2020. 2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases |pdf=|usr=}}
| |
| − | {{tp|p=32358994|t=2020. Asthma and COVID-19: is asthma a risk factor for severe outcomes?|pdf=|usr=}}
| |
| − | {{tp|p=32311145|t=2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience |pdf=|usr=}}
| |
| − | {{tp|p=32243621|t=2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient |pdf=|usr=}}
| |
| − | {{tp|p=32267016|t=2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32380564|t=2020. Caring for Pregnant Patients with COVID-19: Practical Tips Getting from Policy to Practice |pdf=|usr=}}
| |
| − | {{tp|p=32217113|t=2020. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy |pdf=|usr=}}
| |
| − | {{tp|p=32359227|t=2020. Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| |
| − | {{tp|p=32359226|t=2020. COVID-19 and Neonatal Respiratory Care: Current Evidence and Practical Approach |pdf=|usr=}}
| |
| − | {{tp|p=32268381|t=2020. Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32305046|t=2020. Severe COVID-19 during Pregnancy and Possible Vertical Transmission |pdf=|usr=}}
| |
| − | {{tp|p=32330970|t=2020. Successful Treatment of Preterm Labor in Association with Acute COVID-19 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32233067|t=ä. COVID?19 in kidney transplant recipients |pdf=|usr=}}
| |
| − | {{tp|p=32233057|t=ä. Novel Coronavirus?19 (COVID?19) in the immunocompromised transplant recipient: #Flatteningthecurve |pdf=|usr=}}
| |
| − | {{tp|p=32198834|t=ä. Case report of COVID?19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?|pdf=|usr=}}
| |
| − | {{tp|p=32181990|t=ä. Successful recovery of COVID?19 pneumonia in a renal transplant recipient with long?term immunosuppression |pdf=|usr=}}
| |
| − | {{tp|p=32243698|t=ä. Immunosuppression drug?related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis |pdf=|usr=}}
| |
| − | {{tp|p=32329629|t=2020. Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32378314|t=2020. Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options |pdf=|usr=}}
| |
| − | {{tp|p=32368838|t=2020. Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients |pdf=|usr=}}
| |
| − | {{tp|p=32359210|t=2020. Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report |pdf=|usr=}}
| |
| − | {{tp|p=32243690|t=2020. A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32243697|t=2020. COVID-19 in posttransplant patients-report of 2 cases |pdf=|usr=}}
| |
| − | {{tp|p=32243673|t=2020. Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient |pdf=|usr=}}
| |
| − | {{tp|p=32324331|t=2020. COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine |pdf=|usr=}}
| |
| − | {{tp|p=32243672|t=2020. SARS Cov-2 infection in a renal-transplanted patient: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32351040|t=2020. COVID-19 in kidney transplant recipients |pdf=|usr=}}
| |
| − | {{tp|p=32337859|t=2020. Two distinct cases with COVID-19 in kidney transplant recipients |pdf=|usr=}}
| |
| − | {{tp|p=32337790|t=2020. Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics |pdf=|usr=}}
| |
| − | {{tp|p=32330356|t=2020. Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States |pdf=|usr=}}
| |
| − | {{tp|p=32330343|t=2020. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter |pdf=|usr=}}
| |
| − | {{tp|p=32319218|t=2020. A Case of SARS-CoV-2-pneumonia with successful antiviral therapy in a 77-year-old male with heart transplant |pdf=|usr=}}
| |
| − | {{tp|p=32315122|t=2020. COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient |pdf=|usr=}}
| |
| − | {{tp|p=32301155|t=2020. COVID-19 in solid organ transplant recipients: A single-center case series from Spain |pdf=|usr=}}
| |
| − | {{tp|p=32282991|t=2020. Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report |pdf=|usr=}}
| |
| − | {{tp|p=32282986|t=2020. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients |pdf=|usr=}}
| |
| − | {{tp|p=32277555|t=2020. Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report |pdf=|usr=}}
| |
| − | {{tp|p=32282977|t=2020. First case of COVID-19 in a kidney transplant recipient treated with belatacept |pdf=|usr=}}
| |
| − | {{tp|p=32277591|t=2020. Fatal outcome in a liver transplant recipient with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32339251|t=2020. The importance of hypertension as a risk factor for severe illness and mortality in COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 230: |
Zeile 110: |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=32281110|t=2020. Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32077115|t=2020. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32275452|t=2020. COVID-19 with Different Severities: A Multicenter Study of Clinical Features |pdf=|usr=}}
| |
| − | {{tp|p=32267160|t=2020. Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32242738|t=2020. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 250: |
Zeile 122: |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32377965|t=ä. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality |pdf=|usr=}}
| |
| − | {{tp|p=32297520|t=2020. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?|pdf=|usr=}}
| |
| − | {{tp|p=32297519|t=2020. COVID-19 and vitamin D?Is there a link and an opportunity for intervention?|pdf=|usr=}}
| |
| − | {{tp|p=32191676|t=2020. Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?|pdf=|usr=}}
| |
| − | {{tp|p=32286694|t=2020. Letter: Covid-19, and vitamin D Authors reply |pdf=|usr=}}
| |
| − | {{tp|p=32281109|t=2020. Letter: Covid-19, and vitamin D |pdf=|usr=}}
| |
| − | {{tp|p=32339299|t=2020. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?|pdf=|usr=}}
| |
| − | {{tp|p=32330314|t=2020. Is BCG vaccination affecting the spread and severity of COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32349517|t=2020. Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32164424|t=2020. COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease |pdf=|usr=}}
| |
| − | {{tp|p=32358817|t=2020. Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome |pdf=|usr=}}
| |
| − | {{tp|p=32282956|t=2020. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab |pdf=|usr=}}
| |
| − | {{tp|p=32247518|t=2020. COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?|pdf=|usr=}}
| |
| − | {{tp|p=32207983|t=2020. Covid-19 infection and mortality: a physiologist?s perspective enlightening clinical features and plausible interventional strategies |pdf=|usr=}}
| |
| − | {{tp|p=32314704|t=2020. Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency |pdf=|usr=}}
| |
| − | {{tp|p=32359210|t=2020. Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report |pdf=|usr=}}
| |
| − | {{tp|p=32324331|t=2020. COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine |pdf=|usr=}}
| |
| − | {{tp|p=32274985|t=2020. Novel Coronavirus Disease (COVID-19): The Need for Immunoprevention at Industrial Scale |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 279: |
Zeile 131: |
| | {{tp|p=32189463|t=ä. The possibility of COVID?19 transmission from eye to nose |pdf=|usr=}} | | {{tp|p=32189463|t=ä. The possibility of COVID?19 transmission from eye to nose |pdf=|usr=}} |
| | {{tp|p=32189460|t=ä. There may be virus in conjunctival secretion of patients with COVID?19 |pdf=|usr=}} | | {{tp|p=32189460|t=ä. There may be virus in conjunctival secretion of patients with COVID?19 |pdf=|usr=}} |
| − | {{tp|p=32352178|t=2020. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North-supports vitamin D as a factor determining severity Authors reply |pdf=|usr=}}
| + | |
| − | {{tp|p=32311755|t=2020. Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 288: |
Zeile 139: |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32329600|t=2020. Reusable and Recyclable Graphene Masks with Outstanding Superhydrophobic and Photothermal Performances |pdf=|usr=}}
| |
| − | {{tp|p=32320359|t=2020. The Prevalence, Characteristics, and Prevention Status of Skin Injury Caused by Personal Protective Equipment Among Medical Staff in Fighting COVID-19: A Multicenter, Cross-Sectional Study |pdf=|usr=}}
| |
| − | {{ttp|p=32246849|t=2020. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32377950|t=ä. Are we forgetting non-COVID-19-related diseases during lockdown?|pdf=|usr=}}
| |
| − | {{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}}
| |
| − | {{tp|p=32274772|t=2020. Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32344441|t=2020. General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32324618|t=2020. Prehabilitation (in case of stalled operations) May Help Mitigate an Increase in COVID-19 Peripandemic Surgical Morbidity and Mortality |pdf=|usr=}}
| |
| − | {{tp|p=32303077|t=2020. Considerations for Obstetric Care during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32276282|t=2020. Protecting Labor and Delivery Personnel from COVID-19 during the Second Stage of Labor |pdf=|usr=}}
| |
| − | {{tp|p=32282339|t=2020. Staying Active in Isolation: Telerehabilitation for Individuals With the Severe Acute Respiratory Syndrome Coronavirus 2 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32371746|t=2020. Supraglottic Airway?Guided Intubation During the COVID-19 Pandemic: A Closed Technique |pdf=|usr=}}
| |
| − | {{tp|p=32366768|t=2020. Protecting Health Care Workers: Use of a Body Covering Transparent Sheet During and After Intubation of Patients With COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32368850|t=2020. Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors |pdf=|usr=}}
| |
| − | {{tp|p=32359194|t=2020. COVID-19 in Spain: Transplantation in the midst of the pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32359188|t=2020. Strategies to halt 2019 novel coronavirus (COVID-19) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People s Hospital, China |pdf=|usr=}}
| |
| − | {{tp|p=32243677|t=2020. The COVID-19 outbreak in Italy: Initial implications for organ transplantation programs |pdf=|usr=}}
| |
| − | {{tp|p=32330352|t=2020. The Swiss approach to the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32330351|t=2020. The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy |pdf=|usr=}}
| |
| − | {{tp|p=32282982|t=2020. Early impact of COVID-19 on transplant center practices and policies in the United States |pdf=|usr=}}
| |
| − | {{tp|p=32282992|t=2020. Coronavirus disease 2019: Utilizing an ethical framework for rationing absolutely scarce health-care resources in transplant allocation decisions |pdf=|usr=}}
| |
| − | {{tp|p=32323460|t=2020. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach |pdf=|usr=}}
| |
| − | {{tp|p=32282972|t=2020. COVID-19: Thoughts and comments from a tertiary liver transplant center in France |pdf=|usr=}}
| |
| − | {{tp|p=32333545|t=2020. Nonessential Research in the New Normal: The Impact of Novel Coronavirus Disease (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32348556|t=2020. Maximising application of the aerosol box in protecting healthcare workers during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32344456|t=2020. Neuraxial anaesthesia and peripheral nerve blocks during the COVID-19 pandemic: a literature review and practice recommendations |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| | | | |
| Zeile 378: |
Zeile 201: |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| | | | |
| − | *'''[[misc.]]'''}} | + | *'''[[misc.]]''' |
| − | {{tp|p=32374932|t=2020. The role of human biology in addressing the COVID?19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32364256|t=2020. Paediatric ethical issues during the COVID-19 pandemic are not just about ventilator triage |pdf=|usr=}}
| + | |
| − | {{tp|p=32364441|t=2020. Don?t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32364440|t=2020. Reply to Letter to the Editor: ?Don?t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19? |pdf=|usr=}}
| + | |
| − | {{tp|p=32233935|t=2020. COVID-19: is the ACE2 just a foe?|pdf=|usr=}}
| + | |
| − | {{tp|p=32228035|t=2020. COVID-19 Does Not Lead to a ?Typical? Acute Respiratory Distress Syndrome |pdf=|usr=}}
| + | |
| − | {{tp|p=32366740|t=ä. COVID-19 and Avoiding Ibuprofen How Good Is the Evidence?|pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32371744|t=2020. Falsely Low Fibrinogen Levels in COVID-19 Patients on Direct Thrombin Inhibitors |pdf=|usr=}}
| + | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| | | | |
